Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Risks of sulfonylurea drugs in the treatment of diabetes mellitus

next article
18.01.2006

 


Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.


In this careful study, some 5800 patients treated with pills for their diabetes were monitored for an average of about 5 years. Patients who were prescribed a sulfonylurea drug (chlorpropamide, tolbutamide or glyburide) experienced higher mortality rates than those who received metformin. Mortality from all causes and deaths attributable to heart attacks were both higher among patients taking sulfonylureas. Patients taking higher doses and those with better prescription compliance were more likely to die than those prescribed lower doses or who took less of their medication.

Jeffrey A. Johnson | Source: EurekAlert!
Further information: www.ualberta.ca
www.cmaj.ca/pressrelease/pg169.pdf
www.cmaj.ca/pressrelease/pg185.pdf

next article

More articles from Health and Medicine:

nachricht Women with asthma feel worse
06.11.2009 | University of Gothenburg

nachricht Blood test identifies women at risk from Alzheimer's
06.11.2009 | University of Gothenburg

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

Airborne nitrogen shifts aquatic nutrient limitation in pristine lakes

06.11.2009 | Studies and Analyses

Genome sequence for the domestic horse to be unveiled

06.11.2009 | Life Sciences

New Study in Geology Uses Satellite Imagery to Identify Active Magma Systems in East Africa’s Rift Valley

06.11.2009 | Earth Sciences

VideoLinks

Event News

Texas Tech University Hosts Major Textile Conference in India

06.11.2009 | Event News

Brief Highlights of the Fluid Dynamics Conference, Minneapolis

30.10.2009 | Event News

EUROSAFE Forum 2009 Brussels: "Safety Implications of an Increased Demand for Nuclear Energy"

29.10.2009 | Event News